Vaxcyte Inc.

NASDAQ: PCVX · Real-Time Price · USD
32.54
-0.16 (-0.49%)
At close: Aug 18, 2025, 3:00 PM

Vaxcyte Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
387.88M 397.45M 834.66M 68.98M
Short-Term Investments
1.36B 682.78M 96.72M 176.99M
Long-Term Investments
1.39B 162.68M 26.55M 27.12M
Other Long-Term Assets
65.68M 38.66M 5.43M 4.96M
Receivables
20.66M 3.61M n/a n/a
Inventory
n/a n/a -1M -1.2M
Other Current Assets
20.11M 5.96M n/a n/a
Total Current Assets
1.79B 1.1B 942.55M 256.35M
Property-Plant & Equipment
270.15M 110.62M 31.65M 35.91M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.72B 311.96M 63.62M 67.99M
Total Assets
3.51B 1.41B 1.01B 324.34M
Account Payables
48.45M 14.59M 9.79M 6.76M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 5.91M 5.28M
Other Current Liabilities
20.55M 11.06M 17.73M 7.95M
Total Current Liabilities
140.18M 145.34M 40.52M 28.72M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
100K n/a 9K 96K
Total Long-Term Liabilities
65.32M 22.11M 12.04M 11.6M
Total Liabilities
205.5M 167.45M 52.56M 40.32M
Total Debt
71.11M 29.22M 17.94M 16.78M
Common Stock
128K 98K 82K 56K
Retained Earnings
-1.39B -924.39M -522.13M -298.64M
Comprehensive Income
-3.87M 179K -361K -241K
Shareholders Equity
3.31B 1.24B 953.61M 284.02M
Total Investments
2.75B 845.45M 123.27M 204.1M